Achievements applications and future of nanomaterials in cancer immunotherapy

Kairui Zhu1, Weimiao Sun2, Chenhui Ti2

  • 1The Second Medical College of Binzhou Medical University, Yantai, Shandong 264003, China; Department of Biochemistry and Molecular Biology, Binzhou Medical University, Yantai, Shandong, China.

Cancer immunotherapy is a treatment approach that harnesses the body's immune system to fight cancer. Despite the development of various immune-based therapies in recent years, the broad application of immunotherapy drugs is limited by several challenges, including drug delivery issues, dose restrictions, autotoxicity, low tumor permeability, low uptake and response rates, and potential immune-related adverse reactions. To address these challenges, researchers are investigating the use of nanomaterials, which offer advantageous properties, such as easy modification, precise targeting, controlled release, and strong penetration. When reduced to the nanoscale, materials exhibit new properties in fields such as acoustics, optics, electricity, magnetism, thermology, structure, and assembly. These unique properties enable nanomaterials to create distinct internal and external environments, allowing for diverse and personalized therapeutic approaches. This review focuses on two categories of nanomaterials: organic and inorganic. It explores their applications in immunotherapy, chemotherapy, phototherapy, light therapy, photodynamic therapy, radiation therapy, and gene therapy. Lastly, this study discusses the current challenges and potential future directions for the use of nanomaterials in immunotherapy and immune-combination therapy.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
675
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
522
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
2.6K